Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel.
William ChanRadya KumarJulia Fiona-Maree Gilmartin-ThomasIngrid HopperWilliam W KempDanny LiewPublished in: Alimentary pharmacology & therapeutics (2018)
There is no clear evidence of an association between PPI monotherapy and increased cardiovascular risk.